Approximately 117,493 bottles of Mycophenolic Acid Delayed-Release Tablets (360 mg) have been recalled because they failed dissolution testing. This medication is used to prevent organ rejection in transplant patients. "Failed dissolution" means the tablets may not dissolve at the correct rate, which could prevent the body from absorbing the medication properly and potentially reduce its effectiveness.
If the tablets do not dissolve correctly, patients may not receive the intended dose, which can increase the risk of organ rejection. There have been no reports of injuries or illnesses related to this recall at this time.
You have 2 options:
Manufactured by Alkem Laboratories, LTD, INDIA; Distributed by Ascend Laboratories, LLC
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.